STUDY GOALS AND OBJECTIVES
With the increased awareness of the impact of current and emerging infectious diseases, the demand for newer pharmaceutical treatments, vaccines, and environmental products is growing globally.
Under these circumstances, there is need for current and comprehensive reports on infectious diseases covering aspects of detection and treatment, demand trends, project opportunities, and investment levels.
This study examines the worldwide demand for infectious disease prevention and treatment products, their markets, and growth opportunities. This study also investigates the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
This study gives a clear, quantitative picture of the supply-and-demand scenario, and highlights the technological and investment opportunities in the field.
REASONS FOR DOING THE STUDY
This report provides the reader with a detailed analysis of the global infectious disease market. It also discusses technological developments, future trends, and emerging opportunities. This information will be useful for those involved in strategic planning and marketing and sales development.
The major objectives of this study are:
- To assess the current state of infectious diseases on a global basis
- To identify the driving factors for demand of new products and services
- To make available the most current and reliable information on the market size
- To estimate the current global supply and demand scenario broken down by disease type and geographical regions
- To estimate the projected global supply-and-demand scenario over the next 5 years and analyzing it via disease type as well as product types
- To identify the factors influencing this industry and make appropriate recommendations.
SCOPE OF REPORT
This technical market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and industrial products, and an applicable patents section. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated.
This report was prepared with marketing and sales personnel and investors in mind. The audience will obtain a broad view of the social and economic consequences of infectious diseases. Additionally, emphasis on type of disease, major players in that arena, and investment levels will be provided.
METHODOLOGIES AND INFORMATION SOURCES
The data for this report was gathered from primary and secondary sources. Sources include information obtained from industry analysts, manufacturers, trade journals, industry associations, and nongovernmental organizations (NGO), the World Intellectual Property Organization, company reports and press releases, product literature, and government documents. Where precise information was not available, a projection was made using reasonable assumptions and estimates based on historical data. All market data is based on manufacturers’ sales.
Peggy S Lehr is the BCC research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include six healthcare reports and her latest report on the global biopesticides market.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.